[
  {
    "ts": null,
    "headline": "Ideaya Biosciences: Potential Registration-Enabling Darovasertib Study Coming",
    "summary": "Explore the potential of Ideaya Biosciences, Inc.'s Darovasertib in treating uveal melanoma as a monotherapy and in combination therapy. Click for more on IDYA.",
    "url": "https://finnhub.io/api/news?id=58cf062de0b62a43333be43bed26cf79b7dd57ae23ace8f7c108b7af4f624e8e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739205407,
      "headline": "Ideaya Biosciences: Potential Registration-Enabling Darovasertib Study Coming",
      "id": 132638958,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2192903839/image_2192903839.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Explore the potential of Ideaya Biosciences, Inc.'s Darovasertib in treating uveal melanoma as a monotherapy and in combination therapy. Click for more on IDYA.",
      "url": "https://finnhub.io/api/news?id=58cf062de0b62a43333be43bed26cf79b7dd57ae23ace8f7c108b7af4f624e8e"
    }
  },
  {
    "ts": null,
    "headline": "Cautious On Arrowhead Pharmaceuticals' FDA NDA Acceptance Due To Valuation Concerns",
    "summary": "Arrowhead Pharmaceuticals recently received the FDA NDA acceptance for Plozasiran. Read why I believe ARWR stock could be a great buy on dips if they happen.",
    "url": "https://finnhub.io/api/news?id=c0e0ecb614e76b2df98ece704c0f97ce2b3cf6581e379151c4c6916306e2957d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739161367,
      "headline": "Cautious On Arrowhead Pharmaceuticals' FDA NDA Acceptance Due To Valuation Concerns",
      "id": 132630802,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1981445243/image_1981445243.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Arrowhead Pharmaceuticals recently received the FDA NDA acceptance for Plozasiran. Read why I believe ARWR stock could be a great buy on dips if they happen.",
      "url": "https://finnhub.io/api/news?id=c0e0ecb614e76b2df98ece704c0f97ce2b3cf6581e379151c4c6916306e2957d"
    }
  }
]